GlassScriptPhysician profile
Robert S Heidt
NPI 1275532327
$81.95
in general payments reported to CMS, 2019-2025
5 companies · none reported in 2025
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.72 · 2020: $35.23.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $49.64 | 2019-2020 | |
| Pacira Therapeutics, INC. | $19.00 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.31 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Research and ownership
$7,255,280.67 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Heidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.